Pub Date : 2025-06-01Epub Date: 2025-06-30DOI: 10.14245/ns.2449354.677
Wongthawat Liawrungrueang, Ho-Jin Lee, Sang Bum Kim, Sang-Min Park, Hyun-Jin Park
Objective: This study aimed to evaluate the clinical and radiological outcomes of unilateral laminotomy for bilateral decompression (ULBD) using biportal endoscopic spinal surgery (BESS) in patients with central canal stenosis, with and without low-grade degenerative lumbar spondylolisthesis (DLS).
Methods: A retrospective observational study was conducted on 170 patients who underwent BESS-ULBD between 2015 and 2018, with at least 2 years of follow-up. Patients were categorized into 2 groups: group A (68 patients) with central stenosis and low-grade DLS and group B (102 patients) with central stenosis alone. Clinical outcomes were assessed using the visual analogue scale (VAS) for back and leg pain, Oswestry Disability Index (ODI), and Modified MacNab criteria. Radiological assessments included sagittal translation measurements on dynamic flexion-extension radiographs.
Results: Both groups significantly improved clinical outcomes at the final follow-up (p<0.05). Group A's mean VAS scores improved from 3.8±2.4 to 1.9±2.0 for back pain and from 6.4±1.8 to 2.3±2.0 for leg pain. In group B, back pain improved from 3.9±2.5 to 1.7±1.9, and leg pain from 6.6±2.0 to 2.2±2.2. ODI scores also improved significantly in both groups. Radiological evaluation showed no significant changes in sagittal translation postoperatively, indicating preserved spinal stability. Both groups had comparable clinical outcomes, with no major complications reported.
Conclusion: BESS-ULBD is a safe and effective minimally invasive option for managing central canal stenosis, with or without low-grade DLS. This technique provides substantial symptom relief, preserves spinal stability, and presents a promising alternative to more invasive fusion procedures in carefully selected patients.
{"title":"Biportal Endoscopic Decompression for Degenerative Lumbar Spondylolisthesis With Stenosis.","authors":"Wongthawat Liawrungrueang, Ho-Jin Lee, Sang Bum Kim, Sang-Min Park, Hyun-Jin Park","doi":"10.14245/ns.2449354.677","DOIUrl":"10.14245/ns.2449354.677","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the clinical and radiological outcomes of unilateral laminotomy for bilateral decompression (ULBD) using biportal endoscopic spinal surgery (BESS) in patients with central canal stenosis, with and without low-grade degenerative lumbar spondylolisthesis (DLS).</p><p><strong>Methods: </strong>A retrospective observational study was conducted on 170 patients who underwent BESS-ULBD between 2015 and 2018, with at least 2 years of follow-up. Patients were categorized into 2 groups: group A (68 patients) with central stenosis and low-grade DLS and group B (102 patients) with central stenosis alone. Clinical outcomes were assessed using the visual analogue scale (VAS) for back and leg pain, Oswestry Disability Index (ODI), and Modified MacNab criteria. Radiological assessments included sagittal translation measurements on dynamic flexion-extension radiographs.</p><p><strong>Results: </strong>Both groups significantly improved clinical outcomes at the final follow-up (p<0.05). Group A's mean VAS scores improved from 3.8±2.4 to 1.9±2.0 for back pain and from 6.4±1.8 to 2.3±2.0 for leg pain. In group B, back pain improved from 3.9±2.5 to 1.7±1.9, and leg pain from 6.6±2.0 to 2.2±2.2. ODI scores also improved significantly in both groups. Radiological evaluation showed no significant changes in sagittal translation postoperatively, indicating preserved spinal stability. Both groups had comparable clinical outcomes, with no major complications reported.</p><p><strong>Conclusion: </strong>BESS-ULBD is a safe and effective minimally invasive option for managing central canal stenosis, with or without low-grade DLS. This technique provides substantial symptom relief, preserves spinal stability, and presents a promising alternative to more invasive fusion procedures in carefully selected patients.</p>","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":"22 2","pages":"556-565"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-06-30DOI: 10.14245/ns.2449316.658
Lingxiao Chen, Jiaming Ding, Zhuo Chen, David B Anderson, Maja R Radojčić, Ruiyuan Zheng, Qingyu Sun, Wenjian Yuan, Jiuxiao Sun, Runhan Fu, Baoyi Shi, Yujie Chen, Lei Qi, Hengxing Zhou, Shiqing Feng
Objective: This study aimed to determine the rates, causes, and predictive factors of readmissions at different periods following spine surgery, up to 180 days.
Methods: This study utilized data from the 2018 to 2019 Nationwide Readmissions Database and included four postoperative periods: 0 to 7 days, 8 to 30 days, 31 to 90 days, and 91 to 180 days. The causes of readmissions and potential predictive factors were systematically identified. All analyses were performed for each period.
Results: For the 180,281 patients (mean age, 65.4 years) included, 2.4% were readmitted between 0 and 7 days, 3.5% between 8 and 30 days, 3.7% between 31 and 90 days, and 4.3% between 91 and 180 days (cumulative rates: 2.4%, 5.9%, 9.3%, and 12.1%, respectively). The causes of readmissions varied across different periods: surgical site-related causes predominated within the first 30 days, whereas nonsurgical site-related causes were more prevalent from 31 to 180 days; other surgical care complication (e.g., infection) was the most prevalent cause between 0 and 7 days (10.7%) and between 8 and 30 days (29.2%), while spondylopathies/spondyloarthropathy (e.g., spinal stenosis) were the leading causes between 31 and 90 days (12.6%) and between 91 and 180 days (17.5%). The predictive factors associated with readmissions also varied across different periods. For example, patients who underwent fusion was associated with a decreased risk of readmissions between 31 and 180 days (e.g., between 91 and 180 days: odds ratio [OR], 0.79; 95% confidence interval [CI], 0.72-0.86; p<0.001), rather than between 0 and 30 days (e.g., between 0 and 7 days: OR, 0.99; 95% CI, 0.90-1.08; p=0.81).
Conclusion: About 6% of patients with lumbar spinal stenosis who underwent spine surgery were readmitted within 30 days and 12% by 180 days. The causes of readmissions and predictive factors varied by period, providing valuable insights for quality improvement efforts and the burden of readmission reductions.
{"title":"Rates, Causes, and Predictive Factors of Hospital Readmissions After Spine Surgery for Lumbar Spinal Stenosis: A Nationwide Retrospective Cohort Study.","authors":"Lingxiao Chen, Jiaming Ding, Zhuo Chen, David B Anderson, Maja R Radojčić, Ruiyuan Zheng, Qingyu Sun, Wenjian Yuan, Jiuxiao Sun, Runhan Fu, Baoyi Shi, Yujie Chen, Lei Qi, Hengxing Zhou, Shiqing Feng","doi":"10.14245/ns.2449316.658","DOIUrl":"10.14245/ns.2449316.658","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to determine the rates, causes, and predictive factors of readmissions at different periods following spine surgery, up to 180 days.</p><p><strong>Methods: </strong>This study utilized data from the 2018 to 2019 Nationwide Readmissions Database and included four postoperative periods: 0 to 7 days, 8 to 30 days, 31 to 90 days, and 91 to 180 days. The causes of readmissions and potential predictive factors were systematically identified. All analyses were performed for each period.</p><p><strong>Results: </strong>For the 180,281 patients (mean age, 65.4 years) included, 2.4% were readmitted between 0 and 7 days, 3.5% between 8 and 30 days, 3.7% between 31 and 90 days, and 4.3% between 91 and 180 days (cumulative rates: 2.4%, 5.9%, 9.3%, and 12.1%, respectively). The causes of readmissions varied across different periods: surgical site-related causes predominated within the first 30 days, whereas nonsurgical site-related causes were more prevalent from 31 to 180 days; other surgical care complication (e.g., infection) was the most prevalent cause between 0 and 7 days (10.7%) and between 8 and 30 days (29.2%), while spondylopathies/spondyloarthropathy (e.g., spinal stenosis) were the leading causes between 31 and 90 days (12.6%) and between 91 and 180 days (17.5%). The predictive factors associated with readmissions also varied across different periods. For example, patients who underwent fusion was associated with a decreased risk of readmissions between 31 and 180 days (e.g., between 91 and 180 days: odds ratio [OR], 0.79; 95% confidence interval [CI], 0.72-0.86; p<0.001), rather than between 0 and 30 days (e.g., between 0 and 7 days: OR, 0.99; 95% CI, 0.90-1.08; p=0.81).</p><p><strong>Conclusion: </strong>About 6% of patients with lumbar spinal stenosis who underwent spine surgery were readmitted within 30 days and 12% by 180 days. The causes of readmissions and predictive factors varied by period, providing valuable insights for quality improvement efforts and the burden of readmission reductions.</p>","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":"22 2","pages":"523-539"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242733/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Regeneration of corticospinal tract (CST) axons after spinal cord injury (SCI) is a key element in rebuilding neuronal connections to restore voluntary motor function. However, it remains challenging owing to limited effective interventions. This study adopted a modified transcranial optogenetic technique to stimulate CST axon regeneration into the injury site of completely transected SCI and explore the underlying molecular mechanisms.
Methods: A novel optogenetic light emitting diode (LED) device was used to stimulate the brain motor cortex in channelrhodopsin-2-yellow fluorescent protein (ChR2-YFP) transgenic mice to observe the regeneration of CST axons in the injury site of a complete SCI. The LED device was also used In vitro to stimulate the motor cortex slices of the transgenic mouse brain for observing the outgrowth of their neurites.
Results: After transcranial optogenetic stimulation, the pyramidal neurons of bilateral cerebral motor cortices, in ChR2-YFP transgenic mice were activated, CST axons regenerated into the injury site of the spinal cord, and the motor function of the paralyzed hindlimbs improved. Proteomic analysis revealed that CST axon regeneration was associated with the activation of the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway in the cerebral motor cortices. In vitro LED blue light illumination enhanced the outgrowth of neurites from the brain slices of transgenic mice. Treatment with a JAK2/STAT3 inhibitor led to a significant attenuation of neurite outgrowth.
Conclusion: The modified transcranial optogenetic technique stimulated bilateral motor cortices, in the brains of ChR2-YFP transgenic mice. It increased the excitability of pyramidal neurons in the motor cortices, and promoted CST axon regeneration by activating the JAK2/STAT3 pathway, repairing complete SCI.
{"title":"Transcranial Optogenetic Stimulation Promotes Corticospinal Tract Axon Regeneration to Repair Spinal Cord Injury by Activating the JAK2/STAT3 Pathway.","authors":"Yuan-Huan Ma, Hong-Ying Chen, Qing-Shuai Wei, Li-Zhi Peng, Ke-Jun Zhang, Qing-Wen Deng, Lai-Jian Wang, Zhou Liu, Bi-Qin Lai, Ying Ding, Ge Li, Bin Jiang, Yue Lan, Xiang Zeng, Yuan-Shan Zeng","doi":"10.14245/ns.2449312.656","DOIUrl":"10.14245/ns.2449312.656","url":null,"abstract":"<p><strong>Objective: </strong>Regeneration of corticospinal tract (CST) axons after spinal cord injury (SCI) is a key element in rebuilding neuronal connections to restore voluntary motor function. However, it remains challenging owing to limited effective interventions. This study adopted a modified transcranial optogenetic technique to stimulate CST axon regeneration into the injury site of completely transected SCI and explore the underlying molecular mechanisms.</p><p><strong>Methods: </strong>A novel optogenetic light emitting diode (LED) device was used to stimulate the brain motor cortex in channelrhodopsin-2-yellow fluorescent protein (ChR2-YFP) transgenic mice to observe the regeneration of CST axons in the injury site of a complete SCI. The LED device was also used In vitro to stimulate the motor cortex slices of the transgenic mouse brain for observing the outgrowth of their neurites.</p><p><strong>Results: </strong>After transcranial optogenetic stimulation, the pyramidal neurons of bilateral cerebral motor cortices, in ChR2-YFP transgenic mice were activated, CST axons regenerated into the injury site of the spinal cord, and the motor function of the paralyzed hindlimbs improved. Proteomic analysis revealed that CST axon regeneration was associated with the activation of the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway in the cerebral motor cortices. In vitro LED blue light illumination enhanced the outgrowth of neurites from the brain slices of transgenic mice. Treatment with a JAK2/STAT3 inhibitor led to a significant attenuation of neurite outgrowth.</p><p><strong>Conclusion: </strong>The modified transcranial optogenetic technique stimulated bilateral motor cortices, in the brains of ChR2-YFP transgenic mice. It increased the excitability of pyramidal neurons in the motor cortices, and promoted CST axon regeneration by activating the JAK2/STAT3 pathway, repairing complete SCI.</p>","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":"22 2","pages":"311-328"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2024-12-23DOI: 10.14245/ns.2448814.407
Jianwei Lv, Shibo Ma, Duo Shan
Objective: Spinal cord injury (SCI) leads to severe motor and sensory deficits, with limited treatment options. This study investigates how methylprednisolone-loaded nanoparticles (MP-NPs) modulate SCI repair by targeting solute carrier family 16 member 3 (SLC16A3) and reshaping the macrophage-inflammatory microenvironment.
Methods: Transcriptome data were analyzed to identify differentially expressed genes (DEGs) associated with SCI. Immune infiltration and WGCNA (Weighted Gene Co-expression Network Analysis) identified genes linked to M2 macrophage polarization, pinpointing SLC16A3 as a key regulatory factor. MP-NPs were synthesized, characterized, and tested for their effects on macrophage polarization, neuronal protection, and SCI recovery in rats.
Results: We identified 612 DEGs related to inflammation and immune response in SCI. SLC16A3, upregulated in SCI, was downregulated by MP-NPs. In vitro, MP-NPs promoted M2 macrophage polarization, enhanced neuronal survival, and supported neural stem cell differentiation. In vivo, MP-NPs significantly improved motor recovery, reduced inflammation, and facilitated neural repair in SCI rats.
Conclusion: MP-NPs downregulate SLC16A3 and modulate the macrophage-inflammatory environment, promoting neural repair and functional recovery in SCI, offering a promising therapeutic strategy.
{"title":"Precision Nanotherapy for Spinal Cord Injury: Modulating SLC16A3 With Methylprednisolone-Loaded Nanoparticles.","authors":"Jianwei Lv, Shibo Ma, Duo Shan","doi":"10.14245/ns.2448814.407","DOIUrl":"10.14245/ns.2448814.407","url":null,"abstract":"<p><strong>Objective: </strong>Spinal cord injury (SCI) leads to severe motor and sensory deficits, with limited treatment options. This study investigates how methylprednisolone-loaded nanoparticles (MP-NPs) modulate SCI repair by targeting solute carrier family 16 member 3 (SLC16A3) and reshaping the macrophage-inflammatory microenvironment.</p><p><strong>Methods: </strong>Transcriptome data were analyzed to identify differentially expressed genes (DEGs) associated with SCI. Immune infiltration and WGCNA (Weighted Gene Co-expression Network Analysis) identified genes linked to M2 macrophage polarization, pinpointing SLC16A3 as a key regulatory factor. MP-NPs were synthesized, characterized, and tested for their effects on macrophage polarization, neuronal protection, and SCI recovery in rats.</p><p><strong>Results: </strong>We identified 612 DEGs related to inflammation and immune response in SCI. SLC16A3, upregulated in SCI, was downregulated by MP-NPs. In vitro, MP-NPs promoted M2 macrophage polarization, enhanced neuronal survival, and supported neural stem cell differentiation. In vivo, MP-NPs significantly improved motor recovery, reduced inflammation, and facilitated neural repair in SCI rats.</p><p><strong>Conclusion: </strong>MP-NPs downregulate SLC16A3 and modulate the macrophage-inflammatory environment, promoting neural repair and functional recovery in SCI, offering a promising therapeutic strategy.</p>","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":" ","pages":"478-499"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-06-30DOI: 10.14245/ns.2550894.447
Inbo Han
{"title":"From the Editor-in-Chief: Featured Articles in the June 2025 Issue.","authors":"Inbo Han","doi":"10.14245/ns.2550894.447","DOIUrl":"10.14245/ns.2550894.447","url":null,"abstract":"","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":"22 2","pages":"309-310"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-06-30DOI: 10.14245/ns.2550394.197
Jennifer M Hah, Shana C Levine, Saneel Khairnar, Luke Pirrotta, Alma Rechav Ben-Natan, Emily Tse, Gabrielle Hettie, Todd Alamin, Anand Veeravagu, Serena Hu, Tina Hernandez-Boussard
Objective: Preoperative opioid misuse is associated with worse postoperative outcomes. This prospective longitudinal cohort study evaluated the association between preoperative opioid misuse and prolonged pain and opioid use after elective spine surgery; and examined postoperative trajectories of patient-reported outcomes over one year.
Methods: Fifty-two patients undergoing elective spine surgery completed presurgical and weekly postoperative longitudinal assessments of pain and opioid use and monthly assessments of depression, anxiety, sleep disturbance, and physical function. Cox regression analyzed the effect of preoperative opioid misuse on time to pain and opioid cessation while linear mixed-effects models examined longitudinal changes in postoperative outcomes.
Results: Adjusting for age, sex, operative region, number of spinal levels, and any preoperative opioid use, preoperative opioid misuse (COMM-Positive) was associated with a delayed return to baseline opioid dose (hazard ratio [HR], 0.35; 95% confidence interval [CI], 0.14-0.88; p=0.02) and delayed opioid cessation (HR, 0.25; 95% CI, 0.09-0.59; p=0.008). All patients experienced comparable reductions in current and average pain intensity, and pain interference over time. COMM-Positive patients reported a normalization of postoperative anxiety and depression 1 month after surgery with a rebound at 3 months while patients without preoperative opioid misuse remained stable over time.
Conclusion: Preoperative opioid misuse is a significant risk factor for delayed opioid cessation even after adjusting for preoperative opioid use, and is associated with a transient normalization of anxiety and depressive symptoms with a rebound 3 months following spine surgery. Targeted screening and risk reduction strategies are needed for patients reporting preoperative opioid misuse before spine surgery.
{"title":"Preoperative Opioid Misuse Associations With Delayed Opioid Cessation, Pain, and Negative Affect After Spine Surgery.","authors":"Jennifer M Hah, Shana C Levine, Saneel Khairnar, Luke Pirrotta, Alma Rechav Ben-Natan, Emily Tse, Gabrielle Hettie, Todd Alamin, Anand Veeravagu, Serena Hu, Tina Hernandez-Boussard","doi":"10.14245/ns.2550394.197","DOIUrl":"10.14245/ns.2550394.197","url":null,"abstract":"<p><strong>Objective: </strong>Preoperative opioid misuse is associated with worse postoperative outcomes. This prospective longitudinal cohort study evaluated the association between preoperative opioid misuse and prolonged pain and opioid use after elective spine surgery; and examined postoperative trajectories of patient-reported outcomes over one year.</p><p><strong>Methods: </strong>Fifty-two patients undergoing elective spine surgery completed presurgical and weekly postoperative longitudinal assessments of pain and opioid use and monthly assessments of depression, anxiety, sleep disturbance, and physical function. Cox regression analyzed the effect of preoperative opioid misuse on time to pain and opioid cessation while linear mixed-effects models examined longitudinal changes in postoperative outcomes.</p><p><strong>Results: </strong>Adjusting for age, sex, operative region, number of spinal levels, and any preoperative opioid use, preoperative opioid misuse (COMM-Positive) was associated with a delayed return to baseline opioid dose (hazard ratio [HR], 0.35; 95% confidence interval [CI], 0.14-0.88; p=0.02) and delayed opioid cessation (HR, 0.25; 95% CI, 0.09-0.59; p=0.008). All patients experienced comparable reductions in current and average pain intensity, and pain interference over time. COMM-Positive patients reported a normalization of postoperative anxiety and depression 1 month after surgery with a rebound at 3 months while patients without preoperative opioid misuse remained stable over time.</p><p><strong>Conclusion: </strong>Preoperative opioid misuse is a significant risk factor for delayed opioid cessation even after adjusting for preoperative opioid use, and is associated with a transient normalization of anxiety and depressive symptoms with a rebound 3 months following spine surgery. Targeted screening and risk reduction strategies are needed for patients reporting preoperative opioid misuse before spine surgery.</p>","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":"22 2","pages":"451-464"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-04-16DOI: 10.14245/ns.2449314.657
Qinguo Huang, Junhua Ye, Yanyu Wu, Qiang Zhou, Hong Li, Lin Peng, Yuntao Lu
Objective: Our previous study categorized atlanto-occipital joint (AOJ) morphology into 3 types, with types II and III-AOJ associated with Chiari malformation (CM) with and without type II basilar invagination (II-BI), respectively. This study aimed to assess the feasibility of tailoring surgical strategies for patients with CM based on AOJ morphological types.
Methods: We retrospectively studied 212 CM patients who underwent foramen magnum decompression (FMD) or combined occipitocervical fusion (OCF). Patients were divided into 4 groups: (1) pure CM with II-AOJ who underwent FMD (CM-II-FMD); (2) pure CM with III-AOJ who underwent FMD+OCF (CM-III-OCF); (3) CM-III-FMD; and (4) CM+ II-BI with III-AOJ who underwent FMD+OCF (BI-III-OCF). Clinical data, including manifestations, imaging findings, surgical details, and neurological assessments, were analyzed at the final follow-up to assess surgical efficacy.
Results: Patients in the BI-III-OCF, CM-III-OCF, and CM-II-FMD groups exhibited a significant improvement in clinical symptoms (pain, sensory disturbances, motor weakness, gait ataxia, and bladder and bowel dysfunction) compared to preoperative levels (p<0.05). Results from the Japanese Orthopaedic Association scale and Neck Disability Index indicated a significant reduction in the degree of neurological impairment within these groups (p<0.05). Furthermore, the Chicago Chiari Outcome Scale scores indicated superior surgical outcomes for patients in these groups. Imaging analyses demonstrated significant reductions in the syringomyelic segment, syringomyelia width, and tonsillar herniation distance among these patients (p<0.05). However, the CM-III-FMD group did not significantly improve in these areas (p>0.05). Postoperative complications occurred in 4.3% of FMD+OCF patients and 3.3% of FMD-only patients.
Conclusion: AOJ morphological types can guide surgical treatment strategies for CM with or without II-BI. FMD alone is suitable for II-AOJ cases, whereas III-AOJ cases should be treated with FMD combined with OCF.
目的:我们之前的研究将寰枕关节(AOJ)形态分为三种类型,II型和III-AOJ分别与伴有和不伴有II型基底内陷(II- bi)的Chiari畸形(CM)相关。本研究旨在评估基于AOJ形态类型的CM患者定制手术策略的可行性。方法:我们回顾性研究了212例接受枕骨大孔减压(FMD)或枕颈融合(OCF)的CM患者。患者分为四组:(1)单纯CM合并II-AOJ行FMD (CM- ii -FMD);(2)单纯CM伴III-AOJ,行FMD + OCF者(CM- iii -OCF);(3) CM-III-FMD;(4) CM + II-BI伴III-AOJ行FMD + OCF者(BI-III-OCF)。在最后随访时分析临床资料,包括表现、影像学表现、手术细节和神经学评估,以评估手术疗效。结果:与术前相比,BI-III-OCF组、CM-III-OCF组和CM-II-FMD组患者的临床症状(疼痛、感觉障碍、运动无力、步态共济失调、膀胱和肠功能障碍)均有显著改善(p < 0.05)。日本骨科协会评分和颈部残疾指数结果显示,两组患者神经功能损伤程度均显著降低(p < 0.05)。此外,芝加哥Chiari预后量表评分显示,这两组患者的手术预后较好。影像学分析显示,这些患者的脊髓脊髓节段、脊髓脊髓宽度和扁桃体突出距离显著减少(p < 0.05)。而CM-III-FMD组在这些方面无明显改善(p < 0.05)。术后并发症发生率为FMD + OCF患者的4.3%,仅FMD患者的3.3%。结论:AOJ形态类型可指导伴有或不伴有II-BI的CM的手术治疗策略。手足口病单独适用于II-AOJ病例,而III-AOJ病例应联合手足口病治疗。
{"title":"Surgical Strategy Analysis of Chiari Malformation With or Without Type II Basilar Invagination According to the Morphological Types of the Atlanto-Occipital Joint: A Retrospective Study of 212 Patients.","authors":"Qinguo Huang, Junhua Ye, Yanyu Wu, Qiang Zhou, Hong Li, Lin Peng, Yuntao Lu","doi":"10.14245/ns.2449314.657","DOIUrl":"10.14245/ns.2449314.657","url":null,"abstract":"<p><strong>Objective: </strong>Our previous study categorized atlanto-occipital joint (AOJ) morphology into 3 types, with types II and III-AOJ associated with Chiari malformation (CM) with and without type II basilar invagination (II-BI), respectively. This study aimed to assess the feasibility of tailoring surgical strategies for patients with CM based on AOJ morphological types.</p><p><strong>Methods: </strong>We retrospectively studied 212 CM patients who underwent foramen magnum decompression (FMD) or combined occipitocervical fusion (OCF). Patients were divided into 4 groups: (1) pure CM with II-AOJ who underwent FMD (CM-II-FMD); (2) pure CM with III-AOJ who underwent FMD+OCF (CM-III-OCF); (3) CM-III-FMD; and (4) CM+ II-BI with III-AOJ who underwent FMD+OCF (BI-III-OCF). Clinical data, including manifestations, imaging findings, surgical details, and neurological assessments, were analyzed at the final follow-up to assess surgical efficacy.</p><p><strong>Results: </strong>Patients in the BI-III-OCF, CM-III-OCF, and CM-II-FMD groups exhibited a significant improvement in clinical symptoms (pain, sensory disturbances, motor weakness, gait ataxia, and bladder and bowel dysfunction) compared to preoperative levels (p<0.05). Results from the Japanese Orthopaedic Association scale and Neck Disability Index indicated a significant reduction in the degree of neurological impairment within these groups (p<0.05). Furthermore, the Chicago Chiari Outcome Scale scores indicated superior surgical outcomes for patients in these groups. Imaging analyses demonstrated significant reductions in the syringomyelic segment, syringomyelia width, and tonsillar herniation distance among these patients (p<0.05). However, the CM-III-FMD group did not significantly improve in these areas (p>0.05). Postoperative complications occurred in 4.3% of FMD+OCF patients and 3.3% of FMD-only patients.</p><p><strong>Conclusion: </strong>AOJ morphological types can guide surgical treatment strategies for CM with or without II-BI. FMD alone is suitable for II-AOJ cases, whereas III-AOJ cases should be treated with FMD combined with OCF.</p>","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":" ","pages":"500-513"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144003015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-06-30DOI: 10.14245/ns.2550796.398
Seung Woo Suh
{"title":"A Commentary on \"Proximal Thoracic Alignment Change Influences Cervical Sagittal Alignment After Correction Surgery in Patients With Lenke Type 2 Adolescent Idiopathic Scoliosis\".","authors":"Seung Woo Suh","doi":"10.14245/ns.2550796.398","DOIUrl":"10.14245/ns.2550796.398","url":null,"abstract":"","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":"22 2","pages":"364-365"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242726/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2025-06-30DOI: 10.14245/ns.2550730.365
Denis Patterson, Joseph Cheng, Michael Dorsi, David Lee, Eric Lee, Jennifer Lee, Ramana Naidu, Lawrence Poree, Jeffrey Roh, Peter Staats, Michael Y. Oh
{"title":"Establishing a Standardized Fellowship Curriculum for Advanced Minimally Invasive Spine Interventions: A Multidisciplinary Approach to Training and Competency.","authors":"Denis Patterson, Joseph Cheng, Michael Dorsi, David Lee, Eric Lee, Jennifer Lee, Ramana Naidu, Lawrence Poree, Jeffrey Roh, Peter Staats, Michael Y. Oh","doi":"10.14245/ns.2550730.365","DOIUrl":"10.14245/ns.2550730.365","url":null,"abstract":"","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":"22 2","pages":"332-334"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Paravertebral foramen screws (PVFSs) have been developed for better pullout strength than lateral mass screws do and lower the risk of vertebral artery and nerve injury than do pedicle screws. While the original method involves insertion using lateral fluoroscopy, its reliability may be limited. This report is the first to assess the accuracy of PVFS insertion under navigation. Given the inherent inaccuracies associated with navigation systems, the authors propose and evaluate a novel stepwise method of inserting PVFSs, called stepwise PVFS with a focus on achieving the correct screw tip location for good cortical bone purchase.
Methods: The authors conducted a retrospective analysis of 12 patients (78 screws) who underwent cervical spine fixation with stepwise PVFS under O-arm navigation between October 2022 and February 2024. The accuracy of screw placement was evaluated using postoperative computed tomography (CT) scans.
Results: A total of 78 PVFSs were inserted in 5 men and 7 women, with an average age of 75 years (range, 52-85 years). The mean follow-up period was 471 days (range, 47-834 days). There were no adverse events related to screw insertion. Postoperative CT scans revealed that 70 screws (90%) were placed in the ideal position. Among the 8 screws that did not achieve the ideal position, 4 had lateral deviation (located in a lateral mass), whereas the other 4 were too short. There were no cases of screw loosening at the final follow-up.
Conclusion: The present study demonstrates that the stepwise PVFS method under navigation guidance achieves higher accuracy in PVFS placement compared with conventional fluoroscopy-guided PVFS, as reported in previous studies.
{"title":"Optimization of Paravertebral Foramen Screw Placement: A Stepwise Approach Considering O-arm Navigation Errors: Technical Note and Case Series.","authors":"Yu Yamamoto, Yusuke Nishimura, Motonori Ishii, Nobuhisa Fukaya, Eisuke Tsukamoto, Ryuta Saito, Masahito Hara, Masakazu Takayasu","doi":"10.14245/ns.2550110.055","DOIUrl":"10.14245/ns.2550110.055","url":null,"abstract":"<p><strong>Objective: </strong>Paravertebral foramen screws (PVFSs) have been developed for better pullout strength than lateral mass screws do and lower the risk of vertebral artery and nerve injury than do pedicle screws. While the original method involves insertion using lateral fluoroscopy, its reliability may be limited. This report is the first to assess the accuracy of PVFS insertion under navigation. Given the inherent inaccuracies associated with navigation systems, the authors propose and evaluate a novel stepwise method of inserting PVFSs, called stepwise PVFS with a focus on achieving the correct screw tip location for good cortical bone purchase.</p><p><strong>Methods: </strong>The authors conducted a retrospective analysis of 12 patients (78 screws) who underwent cervical spine fixation with stepwise PVFS under O-arm navigation between October 2022 and February 2024. The accuracy of screw placement was evaluated using postoperative computed tomography (CT) scans.</p><p><strong>Results: </strong>A total of 78 PVFSs were inserted in 5 men and 7 women, with an average age of 75 years (range, 52-85 years). The mean follow-up period was 471 days (range, 47-834 days). There were no adverse events related to screw insertion. Postoperative CT scans revealed that 70 screws (90%) were placed in the ideal position. Among the 8 screws that did not achieve the ideal position, 4 had lateral deviation (located in a lateral mass), whereas the other 4 were too short. There were no cases of screw loosening at the final follow-up.</p><p><strong>Conclusion: </strong>The present study demonstrates that the stepwise PVFS method under navigation guidance achieves higher accuracy in PVFS placement compared with conventional fluoroscopy-guided PVFS, as reported in previous studies.</p>","PeriodicalId":19269,"journal":{"name":"Neurospine","volume":"22 2","pages":"514-522"},"PeriodicalIF":3.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242730/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}